ASND logo

Ascendis Pharma A/S (ASND) Interest Expense

Annual Interest Expense

$47.71 M
+$15.35 M+47.43%

December 31, 2023

Summary

Performance

1-Year Change

+47.43%

3-Year Change

+2077.92%

5-Year Change

+31703.47%

15-Year Change

+43307.83%

ASND Interest Expense Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Sector Rank

83.77%
ASND annual interest expense is higher than 83.77% of companies in Healthcare sector

High & Low

All-time High

$47.71 M
ASND annual interest expense is currently at an all-time high

3-Year Low

$4.63 M
ASND annual interest expense is currently +930.93% above its 3-year low

Earnings dates

Last Annual Earnings Report Date

Dec 31, 2023
ASND previous annual earnings announcement was published on Dec 31, 2023

Next Annual Earnings Report Date

Feb 7, 2025
ASND next annual earnings announcement is scheduled for Feb 7, 2025

OtherASNDexpensesmetrics:

Annual Total Expenses

$781.92 M
ASND annual total expenses is $781.92 million

Annual Operating Expenses

$733.86 M
ASND annual total operating expenses is $733.86 million

Annual Cost Of Goods Sold

$48.06 M
ASND annual cost of goods sold is $48.06 million

Annual Income Tax

$7.91 M
ASND annual income tax is $7.91 million

Quarterly Interest Expense

$27.88 M
+$6.75 M+31.93%

September 30, 2024

Summary

Performance

3-Month Change

0%

1-Year Change

+4.42%

3-Year Change

+2596.03%

5-Year Change

+6712.54%

ASND Quarterly Interest Expense Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Sector Rank

87.92%
ASND quarterly interest expense is higher than 87.92% of companies in Healthcare sector

High & Low

All-time High

$83.81 M
ASND quarterly interest expense is currently -66.74% below its historical high of $83.81 million

3-Year Low

$1.52 M
ASND quarterly interest expense is currently +1731.24% above its 3-year low

Earnings dates

Last Quarterly Earnings Report Date

Sep 30, 2024
ASND previous earnings announcement was published on Sep 30, 2024

Next Quarterly Earnings Report Date

Feb 7, 2025
ASND next earnings announcement is scheduled for Feb 7, 2025

OtherASNDexpensesmetrics:

Quarterly Total Expenses

$170.00 M
ASND quarterly total expenses is $170.00 million

Quarterly Operating Expenses

$157.69 M
ASND quarterly total operating expenses is $157.69 million

Quarterly Cost Of Goods Sold

$12.32 M
ASND quarterly cost of goods sold is $12.32 million

Quarterly Income Tax

$1.12 M
ASND quarterly income tax is $1.12 million

TTM Interest Expense

$141.89 M
+$1.18 M+0.84%

September 30, 2024

Summary

Performance

3-Month Change

0%

1-Year Change

+168.41%

3-Year Change

+586.63%

5-Year Change

+1235.5%

ASND TTM Interest Expense Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Sector Rank

89.44%
ASND TTM interest expense is higher than 89.44% of companies in Healthcare sector

High & Low

All-time High

$141.89 M
ASND TTM interest expense is currently at an all-time high

3-Year Low

$18.24 M
ASND TTM interest expense is currently +678.10% above its 3-year low

Earnings dates

Last Quarterly Earnings Report Date

Sep 30, 2024
ASND previous earnings announcement was published on Sep 30, 2024

Next Quarterly Earnings Report Date

Feb 7, 2025
ASND next earnings announcement is scheduled for Feb 7, 2025

OtherASNDexpensesmetrics:

Annual Total Expenses

$781.92 M
ASND annual total expenses is $781.92 million

Annual Operating Expenses

$733.86 M
ASND annual total operating expenses is $733.86 million

TTM Cost Of Goods Sold

$53.84 M
ASND TTM cost of goods sold is $53.84 million

TTM Income Tax

$10.33 M
ASND TTM income tax is $10.33 million

Interest Expense Formula

Interest Expense = Carrying Value of Debt X Effective Interest Rate

ASND Interest Expense Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterlyTTMTTM
1 y1 year+47.4%+4.4%+168.4%
3 y3 years+2077.9%+2596.0%+586.6%
5 y5 years+10000.0%+6712.5%+1235.5%

ASND Interest Expense Highs & Lows

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs lowTTM vs highTTM vs highTTM vs lowTTM vs low
3 y3-yearat high+930.9%-66.7%+1731.2%at high+678.1%
5 y5-yearat high+3390.0%-66.7%+160.8%at high+586.6%
alltimeall timeat high>+9999.0%-66.7%+160.8%at high+586.6%

Ascendis Pharma A/S Interest Expense History

DateAnnualQuarterlyTTM
Sep 2024
-
$27.88 M(+31.9%)
$141.89 M(+0.8%)
Jun 2024
-
$21.13 M(-74.8%)
$140.71 M(+8.4%)
Mar 2024
-
$83.81 M(+823.7%)
$129.76 M(+129.6%)
Dec 2023
$47.71 M(+47.4%)
$9.07 M(-66.0%)
$56.52 M(+6.9%)
Sep 2023
-
$26.70 M(+162.3%)
$52.86 M(-21.9%)
Jun 2023
-
$10.18 M(-3.7%)
$67.72 M(+0.2%)
Mar 2023
-
$10.57 M(+95.0%)
$67.59 M(+7.2%)
Dec 2022
$32.36 M(+599.3%)
$5.42 M(-87.0%)
$63.08 M(+6.6%)
Sep 2022
-
$41.55 M(+313.5%)
$59.18 M(+217.1%)
Jun 2022
-
$10.05 M(+65.9%)
$18.66 M(-19.7%)
Mar 2022
-
$6.06 M(+298.0%)
$23.25 M(+27.5%)
Dec 2021
$4.63 M(+111.3%)
$1.52 M(+47.2%)
$18.24 M(-162.5%)
Sep 2021
-
$1.03 M(-92.9%)
-$29.16 M(-276.2%)
Jun 2021
-
$14.63 M(+1297.3%)
$16.55 M(+24.9%)
Mar 2021
-
$1.05 M(-102.3%)
$13.25 M(+4.4%)
Dec 2020
$2.19 M(+60.2%)
-$45.87 M(-198.1%)
$12.70 M(-78.5%)
Sep 2020
-
$46.74 M(+312.4%)
$59.02 M(+365.1%)
Jun 2020
-
$11.33 M(+2197.7%)
$12.69 M(+16.5%)
Mar 2020
-
$493.30 K(+8.9%)
$10.90 M(+2.6%)
Dec 2019
$1.37 M
$452.90 K(+10.7%)
$10.62 M(+3.6%)
Sep 2019
-
$409.20 K(-95.7%)
$10.26 M(+3.6%)
Jun 2019
-
$9.54 M(+4229.4%)
$9.90 M(+2642.7%)
DateAnnualQuarterlyTTM
Mar 2019
-
$220.40 K(+161.1%)
$360.80 K(-95.9%)
Dec 2018
$150.00 K(+36.5%)
$84.40 K(+73.0%)
$8.75 M(-324.7%)
Sep 2018
-
$48.80 K(+577.8%)
-$3.89 M(+507.2%)
Jun 2018
-
$7200.00(-99.9%)
-$641.40 K(-110.3%)
Mar 2018
-
$8.61 M(-168.6%)
$6.21 M(-1195.7%)
Dec 2017
$109.90 K(+1898.2%)
-$12.56 M(-480.4%)
-$566.80 K(-106.6%)
Sep 2017
-
$3.30 M(-51.9%)
$8.64 M(+50.9%)
Jun 2017
-
$6.86 M(+273.9%)
$5.73 M(-607.5%)
Mar 2017
-
$1.83 M(-154.7%)
-$1.13 M(-1417.5%)
Dec 2016
$5500.00(-17.9%)
-$3.35 M(-965.2%)
$85.70 K(-79.0%)
Sep 2016
-
$387.30 K(>+9900.0%)
$408.00 K(+23.3%)
Jun 2016
-
$0.00(-100.0%)
$330.80 K(-89.3%)
Mar 2016
-
$3.05 M(-200.7%)
$3.08 M(+7792.3%)
Dec 2015
$6700.00(-68.5%)
-$3.03 M(-1076.6%)
$39.00 K(-98.7%)
Sep 2015
-
$310.10 K(-88.7%)
$2.96 M(+9.7%)
Jun 2015
-
$2.75 M(>+9900.0%)
$2.70 M(<-9900.0%)
Mar 2015
-
$10.20 K(-109.5%)
-$8400.00(-127.4%)
Dec 2014
$21.30 K(+100.9%)
-$107.40 K(-319.2%)
$30.70 K(-111.0%)
Sep 2014
-
$49.00 K(+23.1%)
-$278.50 K(-15.0%)
Jun 2014
-
$39.80 K(-19.3%)
-$327.50 K(-10.8%)
Mar 2014
-
$49.30 K(-111.8%)
-$367.30 K(-11.8%)
Dec 2013
$10.60 K(-58.8%)
-$416.60 K
-$416.60 K
Dec 2012
$25.70 K
-
-

FAQ

  • What is Ascendis Pharma A/S annual interest expense?
  • What is the all time high annual interest expense for Ascendis Pharma A/S?
  • What is Ascendis Pharma A/S annual interest expense year-on-year change?
  • What is Ascendis Pharma A/S quarterly interest expense?
  • What is the all time high quarterly interest expense for Ascendis Pharma A/S?
  • What is Ascendis Pharma A/S quarterly interest expense year-on-year change?
  • What is Ascendis Pharma A/S TTM interest expense?
  • What is the all time high TTM interest expense for Ascendis Pharma A/S?
  • What is Ascendis Pharma A/S TTM interest expense year-on-year change?

What is Ascendis Pharma A/S annual interest expense?

The current annual interest expense of ASND is $47.71 M

What is the all time high annual interest expense for Ascendis Pharma A/S?

Ascendis Pharma A/S all-time high annual interest expense is $47.71 M

What is Ascendis Pharma A/S annual interest expense year-on-year change?

Over the past year, ASND annual interest expense has changed by +$15.35 M (+47.43%)

What is Ascendis Pharma A/S quarterly interest expense?

The current quarterly interest expense of ASND is $27.88 M

What is the all time high quarterly interest expense for Ascendis Pharma A/S?

Ascendis Pharma A/S all-time high quarterly interest expense is $83.81 M

What is Ascendis Pharma A/S quarterly interest expense year-on-year change?

Over the past year, ASND quarterly interest expense has changed by +$1.18 M (+4.42%)

What is Ascendis Pharma A/S TTM interest expense?

The current TTM interest expense of ASND is $141.89 M

What is the all time high TTM interest expense for Ascendis Pharma A/S?

Ascendis Pharma A/S all-time high TTM interest expense is $141.89 M

What is Ascendis Pharma A/S TTM interest expense year-on-year change?

Over the past year, ASND TTM interest expense has changed by +$89.03 M (+168.41%)